Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility Study - Full Text View

Sponsored by:	University of New Mexico
Information provided by:	University of New Mexico
ClinicalTrials.gov Identifier:	NCT00322504

Purpose

To assess the efficacy of acupuncture treatment in reducing symptoms of anxiety in women recently diagnosed with cancer.

• To assess the efficacy of acupuncture treatment on improving perceived quality of life in women recently diagnosed with cancer.

Condition	Intervention
Breast Cancer	Procedure: Accupuncture

Genetics Home Reference related topics: breast cancer

MedlinePlus related topics: Acupuncture Anxiety Breast Cancer Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment

Further study details as provided by University of New Mexico:

Estimated Enrollment:	10
Study Start Date:	January 2006
Estimated Study Completion Date:	September 2006

Detailed Description:

This is a feasibility study of acupuncture for anxiety reduction in women with breast cancer. Ten patients will be recruited at the UNM Cancer Research Treatment Center via the Breast Clinic and screened for anxiety. Treatment will consist of 10 acupuncture sessions over 5 weeks. Measures (Hopkins Symptom Checklist, Sheehan Disability Index) will be administered and analyzed for treatment effect on scores.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Woman age 18 years or older excluding the need for parental/guardian permission.
Histologic diagnosis of breast cancer.
Having a minimum anxiety score of 1.75 on the Hopkins Symptom Checklist (HSCL) with sufficient English language proficiency for the investigators to make this determination.
Able to give informed consent.
Willingness to participate in the study and receive 10 acupuncture treatments in 5 weeks.
Ability to fill out questionnaires and communicate with the research staff

Exclusion Criteria:

Males with breast cancer
Psychoses or a major personality disorder
Current use of opiates,

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00322504

Locations

United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87114

Sponsors and Collaborators

University of New Mexico

Investigators

Principal Investigator:

Brian Shelley

University of New Mexico

More Information

Study ID Numbers:	INST 0520C
Study First Received:	May 5, 2006
Last Updated:	November 21, 2006
ClinicalTrials.gov Identifier:	NCT00322504
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Skin Diseases
Breast Neoplasms
Breast Diseases

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 14, 2009